Alterations of Hemostatic Molecular Markers During Acute Large Vessel Occlusion Stroke
BACKGROUND: This study aimed to investigate regional levels of TAT (thrombin-antithrombin complex), PIC (plasmin-α2 plasmin inhibitor complex), t-PAIC (tissue plasminogen activator-plasminogen activator inhibitor complex), sTM (soluble thrombomodulin), and D-dimer, along with their associations with clinical and procedural characteristics in patients with acute ischemic stroke undergoing endovascular thrombectomy.
METHODS AND RESULTS: We retrospectively analyzed 166 consecutive patients with acute ischemic stroke (62±11.54 years of age, 34.3% women) using prospectively maintained clinical databases and blood samples from local ischemic (proximal to thrombus) and systemic (femoral artery, self-control) arterial compartments. Levels of TAT, PIC, t-PAIC, and D-dimer were significantly elevated, whereas sTM was significantly reduced, in local ischemic regions compared with their systemic levels. Each 1-unit increase in ischemic TAT (adjusted odds ratio [aOR], 1.086 [95% CI, 1.03-1.145]; P=0.002; area under the curve [AUC], 0.833) and PIC (aOR, 1.337 [95% CI, 1.087-1.644]; P=0.006; AUC, 0.771) correlated significantly with higher symptomatic intracranial hemorrhage risk. Additionally, each 1-unit increase in ischemic TAT (aOR, 1.076 [95% CI, 1.016-1.139]; P=0.013; AUC, 0.797), PIC (aOR, 1.554 [95% CI, 1.194-2.022]; P=0.001; AUC, 0.798), and sTM (aOR, 0.769 [95% CI, 0.615-0.961]; P=0.021; AUC, 0.756) was significantly associated with an increased risk of an unfavorable 90-day outcome (modified Rankin scale of 3-6). These hemostatic molecules, individually or combined, significantly improved the predictive power of conventional risk factors, as evidenced by significant increases in net reclassification improvement and integrated discrimination improvement (all P<0.01).
CONCLUSIONS: We observed a hyperactive state of the coagulation-fibrinolysis system within the local ischemic region during hyperacute stroke. Rapid automated measurement of hemostatic molecular markers, particularly TAT, PIC, and sTM, during intra-arterial procedures may provide additional information for stroke risk stratification and therapeutic decision-making, and warrants further investigation.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2024 |
---|---|
Erschienen: |
2024 |
Enthalten in: |
Zur Gesamtaufnahme - volume:13 |
---|---|
Enthalten in: |
Journal of the American Heart Association - 13(2024), 3 vom: 06. Feb., Seite e032651 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Xu, Xin [VerfasserIn] |
---|
Links: |
---|
Themen: |
Acute ischemic stroke |
---|
Anmerkungen: |
Date Completed 07.02.2024 Date Revised 07.02.2024 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1161/JAHA.123.032651 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM367842262 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | NLM367842262 | ||
003 | DE-627 | ||
005 | 20240207232304.0 | ||
007 | cr uuu---uuuuu | ||
008 | 240131s2024 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1161/JAHA.123.032651 |2 doi | |
028 | 5 | 2 | |a pubmed24n1283.xml |
035 | |a (DE-627)NLM367842262 | ||
035 | |a (NLM)38293908 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Xu, Xin |e verfasserin |4 aut | |
245 | 1 | 0 | |a Alterations of Hemostatic Molecular Markers During Acute Large Vessel Occlusion Stroke |
264 | 1 | |c 2024 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 07.02.2024 | ||
500 | |a Date Revised 07.02.2024 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a BACKGROUND: This study aimed to investigate regional levels of TAT (thrombin-antithrombin complex), PIC (plasmin-α2 plasmin inhibitor complex), t-PAIC (tissue plasminogen activator-plasminogen activator inhibitor complex), sTM (soluble thrombomodulin), and D-dimer, along with their associations with clinical and procedural characteristics in patients with acute ischemic stroke undergoing endovascular thrombectomy | ||
520 | |a METHODS AND RESULTS: We retrospectively analyzed 166 consecutive patients with acute ischemic stroke (62±11.54 years of age, 34.3% women) using prospectively maintained clinical databases and blood samples from local ischemic (proximal to thrombus) and systemic (femoral artery, self-control) arterial compartments. Levels of TAT, PIC, t-PAIC, and D-dimer were significantly elevated, whereas sTM was significantly reduced, in local ischemic regions compared with their systemic levels. Each 1-unit increase in ischemic TAT (adjusted odds ratio [aOR], 1.086 [95% CI, 1.03-1.145]; P=0.002; area under the curve [AUC], 0.833) and PIC (aOR, 1.337 [95% CI, 1.087-1.644]; P=0.006; AUC, 0.771) correlated significantly with higher symptomatic intracranial hemorrhage risk. Additionally, each 1-unit increase in ischemic TAT (aOR, 1.076 [95% CI, 1.016-1.139]; P=0.013; AUC, 0.797), PIC (aOR, 1.554 [95% CI, 1.194-2.022]; P=0.001; AUC, 0.798), and sTM (aOR, 0.769 [95% CI, 0.615-0.961]; P=0.021; AUC, 0.756) was significantly associated with an increased risk of an unfavorable 90-day outcome (modified Rankin scale of 3-6). These hemostatic molecules, individually or combined, significantly improved the predictive power of conventional risk factors, as evidenced by significant increases in net reclassification improvement and integrated discrimination improvement (all P<0.01) | ||
520 | |a CONCLUSIONS: We observed a hyperactive state of the coagulation-fibrinolysis system within the local ischemic region during hyperacute stroke. Rapid automated measurement of hemostatic molecular markers, particularly TAT, PIC, and sTM, during intra-arterial procedures may provide additional information for stroke risk stratification and therapeutic decision-making, and warrants further investigation | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a acute ischemic stroke | |
650 | 4 | |a coagulation | |
650 | 4 | |a endovascular thrombectomy | |
650 | 4 | |a fibrinolysis | |
650 | 4 | |a outcome | |
650 | 7 | |a Tissue Plasminogen Activator |2 NLM | |
650 | 7 | |a EC 3.4.21.68 |2 NLM | |
650 | 7 | |a Hemostatics |2 NLM | |
650 | 7 | |a Biomarkers |2 NLM | |
700 | 1 | |a Song, Yiming |e verfasserin |4 aut | |
700 | 1 | |a Cao, Wenbo |e verfasserin |4 aut | |
700 | 1 | |a Bai, Xuesong |e verfasserin |4 aut | |
700 | 1 | |a Wang, Xinyu |e verfasserin |4 aut | |
700 | 1 | |a Gao, Peng |e verfasserin |4 aut | |
700 | 1 | |a Chen, Jian |e verfasserin |4 aut | |
700 | 1 | |a Chen, Yanfei |e verfasserin |4 aut | |
700 | 1 | |a Yang, Bin |e verfasserin |4 aut | |
700 | 1 | |a Wang, Yabing |e verfasserin |4 aut | |
700 | 1 | |a Chen, Fei |e verfasserin |4 aut | |
700 | 1 | |a Ma, Qingfeng |e verfasserin |4 aut | |
700 | 1 | |a Yu, Bo |e verfasserin |4 aut | |
700 | 1 | |a Jiao, Liqun |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Journal of the American Heart Association |d 2012 |g 13(2024), 3 vom: 06. Feb., Seite e032651 |w (DE-627)NLM222412712 |x 2047-9980 |7 nnns |
773 | 1 | 8 | |g volume:13 |g year:2024 |g number:3 |g day:06 |g month:02 |g pages:e032651 |
856 | 4 | 0 | |u http://dx.doi.org/10.1161/JAHA.123.032651 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 13 |j 2024 |e 3 |b 06 |c 02 |h e032651 |